RSV Diagnostics Market Expected to Reach USD 2.3 Bn by 2030

►Global RSV Diagnostics Market Soars: USD 1.2 Bn in 2023 to USD 2.3 Bn by 2030, CAGR 8.17%

The global Respiratory Syncytial Virus (RSV) diagnostics market is witnessing dynamic growth. Valued at USD 1.2 billion in 2023, it's projected to reach USD 2.3 billion by 2030, reflecting a strong compound annual growth rate (CAGR) of 8.17%. This surge is driven by rising RSV incidence, a growing neonatal and elderly population, and the expansion of advanced in‐vitro and point‐of‐care testing solutions.

Curious to peek inside? Grab your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/112452/

►Competitive Landscape

Major players include Abbott, Quidel, BD, Roche Diagnostics, Siemens Healthineers, BD, Luminex, Hologic, BioMérieux, Cepheid, among others . The competitive focus is on:

Rapid POC deployment (Abbott's Panbio, Quidel's Sofia).

AI‐powered molecular platforms (Siemens Healthineers).

Affordable mass-produced antigen kits (Bioperfectus).

►Regional Insights

♦ United States - Growth & Opportunity
The U.S. dominates the North American RSV diagnostics landscape, with market leadership fueled by heavy investment in R&D and widespread adoption of molecular and rapid antigen tests. Abbott's Panbio RSV Rapid POC Test-delivering results in just 5 minutes-has notably reshaped market dynamics. Rapid, accurate diagnosis has become a critical competitive edge, as clinical settings seek to optimize patient care and cost efficiency.

♦ Europe - Trends & Consolidation
Europe is following suit, led by Germany and the UK's adoption of AI‐enhanced molecular diagnostics. Siemens Healthineers has launched collaborations with academia for AI-powered RSV solutions, while government backing in the UK and France is accelerating deployment of national diagnostic programs . This region is witnessing consolidation through strategic alliances between healthcare institutions and diagnostic companies.

Eager to discover what's within? Secure your sample copy of the report today:https://www.maximizemarketresearch.com/request-sample/112452/

♦ Asia Pacific - Updation & Opportunity
Asia Pacific is the fastest‐growing region, supported by a CAGR exceeding 8% and substantial healthcare spending. Population surges in China and India, coupled with investments in affordable point‐of‐care tests, are broadening diagnostic access. Bioperfectus (China) has secured funding to scale rapid antigen test manufacturing, strengthening local capacity and market reach .

♦ Middle East & Africa - Growth & Trends
MEA is gaining momentum thanks to rising healthcare infrastructure investments in GCC countries. Nations like Saudi Arabia and the UAE are integrating advanced RSV diagnostics, presenting new growth pathways. Despite these gains, adoption remains moderate compared to Western markets, with expansion primarily in hospital and laboratory settings.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:https://www.maximizemarketresearch.com/request-sample/112452/

► Market Segmentation: In-Depth Analysis:

by Product

Kits and Assays
Instruments
Other

The Kits and Assays category of the RSV Diagnostics Market had the biggest market share in 2023. The extensive use of diagnostic kits and assays for the quick and effective diagnosis of respiratory syncytial virus (RSV) is responsible for this dominance. For medical personnel, kits and assays provide a practical and easily available approach that enables prompt and precise diagnosis of RSV infections, especially in high-risk groups like the elderly and babies.

by Diagnostic Methods

Molecular Diagnostics
Immunoassays
Rapid Antigen Tests

The Hospitals and Clinics segment is the most dominant end-user category in the RSV Diagnostics Market. The critical role these healthcare venues play in the identification, management, and treatment of Respiratory Syncytial Virus (RSV) infections serves as the foundation for this dominance. As the main locations of care, hospitals and clinics treat a wide range of patients, including those who are more susceptible, such as the elderly and newborns.

by End User

Hospitals and Clinics
Diagnostic Laboratories
Research Institutes
Others

For deeper market insights, peruse the summary of the research report:https://www.maximizemarketresearch.com/market-report/global-rsv-diagnostics-market/112452/

► Learn about the top players driving innovation in the Market :

North America
1. Abbott (USA)
2. Royal Philips (Netherlands)
3. Quventus Medical (Canada)
4. Roche Diagnostics (Switzerland)
5. BD (USA)
6. Luminex Corporation (USA)
7. Quidel Corporation (USA)
8. Diagnostic Innovations (Australia)
Europe
1. Siemens Healthineers (Germany)
2. GSK & AstraZeneca (UK)
3. Hologic Inc. (USA)
4. Vall d'Hebron University Hospital (Spain)
5. ANRS-PEA2 program (France)
6. Royal Philips (Netherlands)
7. Vall d'Hebron University Hospital (Spain)
8. University of Bologna (Italy)
9. Qventus Medical (Canada)
10. Diagnostic Innovations (Australia)
Asia Pacific
1. Bioperfectus (China)
2. Luminex Corporation (USA)
3. OSANG Healthcare Co., Ltd. (South Korea)
4. Mindray Medical International Ltd. (China)
5. Shenzhen YHLO Biotech Co., Ltd. (China)

► Get Market Research Latest Trends :

♦ Global Alzheimer's Disease Diagnostic Market : https://www.maximizemarketresearch.com/market-report/global-alzheimers-disease-diagnostic-market/116921/

♦ Heparin Market : https://www.maximizemarketresearch.com/market-report/global-heparin-market/103436/

♦ global Hemophilia Market : https://www.maximizemarketresearch.com/market-report/global-hemophilia-market/67045/

♦ global Knee Replacement Market : https://www.maximizemarketresearch.com/market-report/global-knee-replacement-market/57801/

♦ Global Flow Cytometry Products Market : https://www.maximizemarketresearch.com/market-report/global-flow-cytometry-products-market/86969/

♦ Global Polio Vaccines Market : https://www.maximizemarketresearch.com/market-report/global-polio-vaccines-market/25422/

♦ Global Forensic Swabs Market: https://www.maximizemarketresearch.com/market-report/global-forensic-swabs-market/111325/

♦ Global Granulocyte Macrophage Colony Stimulating Factor Market : https://www.maximizemarketresearch.com/market-report/global-granulocyte-macrophage-colony-stimulating-factor-market/69429/

♦ Global Ankle-Brachial Index Measurement Market : https://www.maximizemarketresearch.com/market-report/global-ankle-brachial-index-measurement-market/84325/

♦ global N95 Mask Market : https://www.maximizemarketresearch.com/market-report/global-n95-mask-market/105931/

♦ Global Rheumatoid Arthritis Diagnosis Market : https://www.maximizemarketresearch.com/market-report/global-rheumatoid-arthritis-diagnosis-market/112472/

♦ Global Dialysis Disposable Devices Market : https://www.maximizemarketresearch.com/market-report/global-dialysis-disposable-devices-market/106788/

♦ Oral Solid Dosage Pharmaceutical Formulation Market : https://www.maximizemarketresearch.com/market-report/oral-solid-dosage-pharmaceutical-formulation-market/121388/

♦ Oil Change Service Market : https://www.maximizemarketresearch.com/market-report/oil-change-service-market/201385/

♦ Inhalable Drug Market : https://www.maximizemarketresearch.com/market-report/inhalable-drug-market/123389/

► Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

► About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.